Geriatric nutritional risk index as a prognostic factor in elderly patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with cisplatin

被引：0
|
作者：
Fujiwara, Y. [1 ]
Sato, Y. [2 ]
Fukuda, N. [2 ]
Hayashi, N. [2 ]
Wang, X. [2 ]
Nakano, K. [2 ]
Ohmoto, A. [2 ]
Urasaki, T. [2 ]
Ono, M. [2 ]
Tomomatsu, J. [2 ]
Toshiyasu, T. [3 ]
Mitani, H. [4 ]
Takahashi, S. [2 ]
机构：
[1] Icahn Sch Med Mt Sinai, Mt Sinai Beth Israel, Med, New York, NY USA
[2] Canc Inst Hosp JFCR, Med Oncol, Tokyo, Japan
[3] Canc Inst Hosp JFCR, Radiat Oncol, Tokyo, Japan
[4] Canc Inst Hosp JFCR, Head & Neck Oncol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.820
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
696P
引用
收藏
页码：S861 / S861
页数：1
相关论文
共 50 条
  • [1] The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin
    Fujiwara, Yu
    Sato, Yasuyoshi
    Hayashi, Naomi
    Fukuda, Naoki
    Wang, Xiaofei
    Nakano, Kenji
    Ohmoto, Akihiro
    Urasaki, Tetsuya
    Ono, Makiko
    Tomomatsu, Junichi
    Toshiyasu, Takashi
    Mitani, Hiroki
    Takahashi, Shunji
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (05)
  • [2] The Geriatric Nutritional Risk Index as a Prognostic Factor in Patients with Advanced Head and Neck Cancer
    Nakayama, Masahiro
    Gosho, Masahiko
    Adachi, Masahiro
    Ii, Rieko
    Matsumoto, Shin
    Miyamoto, Hidetaka
    Hirose, Yuki
    Nishimura, Bungo
    Tanaka, Shuho
    Wada, Tetsuro
    Tabuchi, Keiji
    LARYNGOSCOPE, 2021, 131 (01): : E151 - E156
  • [3] Pretreatment nutritional risk as a prognostic factor in head and neck cancer patients receiving radiotherapy or chemoradiotherapy
    Liu, Weixin
    Gao, Li
    Huang, Xiaodong
    Luo, Jingwei
    Zhang, Shiping
    Wang, Kai
    Qu, Yuan
    Xiao, Jianping
    Xu, Guozhen
    Li, Yexiong
    Yi, Junlin
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2019, 28 (02) : 223 - 229
  • [4] Should Cetuximab Replace Cisplatin for Definitive Chemoradiotherapy in Locally Advanced Head and Neck Cancer?
    Riaz, Nadeem
    Sherman, Eric J.
    Fury, Matthew
    Lee, Nancy
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) : 287 - 288
  • [5] GPS as a prognostic index and a predictor of toxicity in early or locally advanced head and neck cancer patients treated with radiotherapy or definitive chemoradiotherapy
    Bui, Simona
    Pietri, Elisabetta
    Coriano, Matilde
    Luca, Isella
    Mazzaschi, Giulia
    Tommasi, Chiara
    Garajova, Ingrid
    Grondelli, Claudia
    ORAL ONCOLOGY, 2021, 118
  • [6] Chemoradiotherapy as Definitive Treatment for Elderly Patients with Head and Neck Cancer
    von der Gruen, Jens Mueller
    Martin, Daniel
    Stoever, Timo
    Ghanaati, Shahram
    Roedel, Claus
    Balermpas, Panagiotis
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [7] Chemoradiotherapy as definitive treatment for elderly patients with head and neck cancer
    von der Gruen, Mueller J.
    Martin, D.
    Stoever, T.
    Ghanaati, S.
    Roedel, C.
    Balermpas, P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S130 - S130
  • [8] Capecitabine chemoradiotherapy in locally advanced head and neck cancer - An alternative to cisplatin?
    Mais, L.
    Slevin, N. J.
    Sykes, A. J.
    Yap, B. K.
    Swindell, R.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S50 - S50
  • [9] Variations in the use of definitive chemoradiotherapy and immunoradiotherapy for patients with locally advanced head and neck cancer.
    Mukkamalla, Shiva Kumar Reddy
    Rathore, Ritesh
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy
    Jianjian Qiu
    Jun Yang
    Yilin Yu
    Zhiping Wang
    Hancui Lin
    Dongmei Ke
    Hongying Zheng
    Jiancheng Li
    Qiwei Yao
    BMC Cancer, 23
12345